Synthesis of a new prostaglandin endoperoxide (PGH2) analog and its function as an inhibitor of the biosynthesis of thromboxane A2 (TBXA2)
β Scribed by E.J. Corey; Haruki Niwa; Miriam Bloom; Peter W. Ramwell
- Publisher
- Elsevier Science
- Year
- 1979
- Tongue
- French
- Weight
- 212 KB
- Volume
- 20
- Category
- Article
- ISSN
- 0040-4039
No coin nor oath required. For personal study only.
β¦ Synopsis
Since the discovery that the prostaglandin endoperoxides PGG2 and PGH2 are convertedenzymically to the highly unstable but biologically potent substance thromboxane A2 l-3 by a relatively straightforward mechanism, it has been clear that various synthetic analogs of the PG endoperoxides would be of great interest as possible inhibitors of thromboxane A2 synthetase. Such inhibitors, if both potent and highly selective for TBXA2 synthetase, would be very useful tools for biological research and possibly interesting as antithromhotic agents. A sizeable number of significant papers dealing with both PG and non-PG derivatives as inhibitors of TBXA2 synthetase have already appeared.
π SIMILAR VOLUMES
## Abstract ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 100 leading journals. To access a ChemInform Abstract of an article which was published elsewhere, please select a βFull Textβ option. The original article is trackable v
A group of rofecoxib analogs, having a sulfonylazide (SO 2 N 3 ) substituent in place of the methanesulfonyl (SO 2 CH 3 ) pharmacophore at the meta-position viz 3-( 4-methyl, 4-methoxy, or 4-ethoxyphenyl)-4-(3-sulf o n y l a z i d o p h e n y l ) -2 ( 5H)furanone (7 a -c) and p a r a-position v i z